The Use of Inhaled Nitric Oxide in the Management of Acute Respiratory Distress Syndrome
DOI:
https://doi.org/10.56294/hl2025627Keywords:
COVID-19, Multiple Organ Failure Syndrome (MOFS), inhaled nitric oxide (inhNO), acute respiratory distress syndrome (ARDS), patientsAbstract
Acute Respiratory Distress Syndrome (ARDS) Patients' Lung Function (PLF), Morbidity (M), and Death were the primary outcomes the researchers were interested in examining. The standard therapy, or the inhaled nitric oxide inhNO treatment, was administered to 30 ARDS patients divided into two groups. It has been shown that 0.5 to 40 ppm of inhNO is the ideal daily dosage. All treatment methods were standard. In 25% of ARDS Patients, sepsis was the underlying cause. In the first 24 hours after inhNO, patients had a considerable increase in their hypoxia score, from 114.2 to 170.4 mm Hg. Similar decreases in venous admixture also occurred in the inhNO group to the control group. InhNO did not continue to have any positive effects beyond the first day of therapy. Forty percent of the inhNO group remained alive and weaned off mechanical ventilation thirty days following randomization, whereas only 33.3% of the control group did so. With Multiple Organ Failure Syndrome (MOFS) as the primary cause of death, the 30-day mortality rate for both groups was comparable. According to the research, inhNO might improve gas exchange but did not lower mortality in this group.
References
1. Emeriaud G, López-Fernández YM, Iyer NP, Bembea MM, Agulnik A, Barbaro RP, Baudin F, Bhalla A, De Carvalho WB, Carroll CL, Cheifetz IM. Executive summary of the second international guidelines for the diagnosis and management of pediatric acute respiratory distress syndrome (PALICC-2). Pediatric critical care medicine. 2023 Feb 1;24(2):143-68. https://doi.org/10.1097/PCC.0000000000003147.
2. Li Y. The Overlooked Side Effect-A Case of Inhaled Nitric Oxide-induced Methemoglobinemia in Severe Acute Respiratory Distress Syndrome. InB104. TOP CASE REPORTS OF MECHANICAL VENTILATION/ARDS FROM THE PAST YEAR 2023 May (pp. A4336-A4336). American Thoracic Society.
3. Ganeriwal S, Alves dos Anjos G, Schleicher M, Hockstein MA, Tonelli AR, Duggal A, Siuba MT. Right ventricle-specific therapies in acute respiratory distress syndrome: a scoping review. Critical Care. 2023 Mar 12;27(1):104. https://doi.org/10.1186/s13054-023-04395-9.
4. Kobayashi J, Murata I. Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome. Annals of intensive care. 2020 Dec;10:1-2. https://doi.org/10.1186/s13613-020-00681-9.
5. Ramji HF, Hafiz M, Altaq HH, Hussain ST, Chaudry F. Acute respiratory distress syndrome; a review of recent updates and a glance into the future. Diagnostics. 2023 Apr 24;13(9):1528. https://doi.org/10.3390/diagnostics13091528.
6. Slobod D, Damia A, Leali M, Spinelli E, Mauri T. Pathophysiology and clinical meaning of ventilation-perfusion mismatch in the acute respiratory distress syndrome. Biology. 2022 Dec 30;12(1):67. https://doi.org/10.3390/biology12010067 .
7. Guan Y, Jin Y, Lu Y, Ao D, Gu P, Yang J, Liu G, Han S. Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide. BMC Pregnancy and Childbirth. 2023 Apr 22;23(1):276. https://doi.org/10.1186/s12884-023-05558-w.
8. Lau VI, Mah GD, Wang X, Byker L, Robinson A, Milovanovic L, Alherbish A, Odenbach J, Vadeanu C, Lu D, Smyth L. Intrapulmonary and intracardiac shunts in adult COVID-19 versus non-COVID acute respiratory distress syndrome ICU patients using echocardiography and contrast bubble studies (COVID-shunt study): a prospective, observational cohort study. Critical care medicine. 2023 Aug 1;51(8):1023-32. https://doi.org/10.1097/CCM.0000000000005848.
9. Chen L, Li J, Shi Y. Clinical characteristics and outcomes in neonates with perinatal acute respiratory distress syndrome in China: a national, multicentre, cross-sectional study. EClinicalMedicine. 2023 Jan 1;55. https://doi.org/10.1016/j.eclinm.2022.101739 .
10. Mandal SM. Nitric oxide mediated hypoxia dynamics in COVID-19. Nitric Oxide. 2023 Apr 1;133:18-21. https://doi.org/10.1016/j.niox.2023.02.002.
11. Lim MJ, Lakshminrusimha S, Hedriana H, Albertson T. Pregnancy and severe ARDS with COVID-19: epidemiology, diagnosis, outcomes and treatment. InSeminars in Fetal and Neonatal Medicine 2023 Feb 1 (Vol. 28, No. 1, p. 101426). WB Saunders. https://doi.org/10.1016/j.siny.2023.101426.
12. Chen Y, Wu Y, Zhu L, Chen C, Xu S, Tang D, Jiao Y, Yu W. METTL3-mediated N6-methyladenosine modification of Trim59 mRNA protects against sepsis-induced acute respiratory distress syndrome. Frontiers in Immunology. 2022 May 25;13:897487. https://doi.org/10.3389/fimmu.2022.897487
13. Abman SH, Fox NR, Malik MI, Kelkar SS, Corman SL, Rege S, Bhaloo J, Shah R, Shei RJ, Saporito D, Shamseddine N. Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome. Drugs in Context. 2022 Apr 11;11. https://doi.org/10.7573/dic.2022-1-4.
14. Bonizzoli M, Lazzeri C, Cianchi G, Guetti C, Fulceri GE, Socci F, Peris A. Effects of rescue inhaled nitric oxide on right ventricle and pulmonary circulation in severe COVID-related acute respiratory distress syndrome. Journal of Critical Care. 2022 Dec 1;72:153987. https://doi.org/10.1016/j.jcrc.2022.153987.
15. Vives M, Gascó I, Pla G, Maciel JL, Hernandez AR, Roman KR, Parramon F. Inhaled nitric oxide in acute severe pulmonary hypertension and severe acute respiratory distress syndrome secondary to COVID-19 pneumonia: a case report. The American Journal of Case Reports. 2022 Oct 25;23:e937147-1. https://doi.org/10.12659/AJCR.937147.
16. Piecek J, Valentino T, Aust R, Harris L, Hancock J, Hardman C, van Poppel SF. The use of nitric oxide as a rescue modality for severe adult acute respiratory distress syndrome patients, including COVID-19, in critical care rotor transport: a retrospective community outcome study. Air Medical Journal. 2022 Sep 1;41(5):427-31. https://doi.org/10.1016/j.amj.2022.06.002 .
17. Bosch NA, Law AC, Vail EA, Gillmeyer KR, Gershengorn HB, Wunsch H, Walkey AJ. Inhaled nitric oxide vs epoprostenol during acute respiratory failure: An observational target trial emulation. Chest. 2022 Dec 1;162(6):1287-96. https://doi.org/10.1016/j.chest.2022.08.001.
18. Petit M, Jullien E, Vieillard-Baron A. Right ventricular function in acute respiratory distress syndrome: impact on outcome, respiratory strategy and use of veno-venous extracorporeal membrane oxygenation. Frontiers in Physiology. 2022 Jan 14;12:797252. https://doi.org/10.3389/fphys.2021.797252.
19. Faraj R, Liang Y, Feng A, Wu J, Black SM, Wang T. Exploring m6A‐RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome. Pulmonary Circulation. 2023 Apr;13(2):e12230. https://doi.org/10.1002/pul2.12230.
20. Maqbool S. and Tahir H. The therapeutic role of Almitrine and inhaled Nitric Oxide (iNO) as rescue therapy in patients of acute respiratory distress syndrome (ARDS) due to COVID-19-A Narrative Review. Himalayan Journal of Medicine and Surgery, 2022, 3(3).
21. Nasrullah A, Virk S, Shah A, Jacobs M, Hamza A, Sheikh AB, Javed A, Butt MA, Sangli S. Acute respiratory distress syndrome and the use of inhaled pulmonary vasodilators in the COVID-19 era: a narrative review. Life. 2022 Nov 2;12(11):1766. https://doi.org/10.3390/life12111766.
22. Verheijen AC, Janssen EE, van der Putten ME, van Horck MW, van Well GT, Van Loo IH, Hütten MC, Van Mechelen K. Management of severe neonatal respiratory distress due to vertical transmission of severe acute respiratory syndrome coronavirus 2: a case report. Journal of medical case reports. 2022 Mar 28;16(1):140. https://doi.org/10.1186/s13256-022-03364-0.
23. Sanfilippo F, Palumbo GJ, Bignami E, Pavesi M, Ranucci M, Scolletta S, Pelosi P, Astuto M. Acute respiratory distress syndrome in the perioperative period of cardiac surgery: predictors, diagnosis, prognosis, management options, and future directions. Journal of Cardiothoracic and Vascular Anesthesia. 2022 Apr 1;36(4):1169-79. https://doi.org/10.1053/j.jvca.2021.04.024.
24. Fanelli V, Giani M, Grasselli G, Mojoli F, Martucci G, Grazioli L, Alessandri F, Mongodi S, Sales G, Montrucchio G, Pizzi C. Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study. Critical Care. 2022 Feb 5;26(1):34. https://doi.org/10.1186/s13054-022-03906-4.
25. Ghosh A, Joseph B, Anil S. Nitric oxide in the management of respiratory consequences in COVID-19: a scoping review of a different treatment approach. Cureus. 2022 Apr 5;14(4). https://doi.org/10.7759/cureus.23852.
26. Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, Kensara R, Alfahed A, Vishwakarma R, Al Haji H, Almohaimid N. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study. Critical Care. 2022 Oct 3;26(1):304. https://doi.org/10.1186/s13054-022-04158-y.
27. Dewantoro D, Davenport R, Goh JY, Bakhshi A, Ali A. The effect of different types of bariatric surgery on levothyroxine requirement in hypothyroid bariatric patients. Cureus. 2022 Jun 21;14(6). https://doi.org/10.7759/cureus.26165.
28. Shei RJ, Baranauskas MN. More questions than answers for the use of inhaled nitric oxide in COVID-19. Nitric Oxide. 2022 Jul 1;124:39-48. https://doi.org/10.1016/j.niox.2022.05.001.
29. Brown CJ, Rubel N, Lai J, Ward C, McLean J, Wheelock M, Steuerwald M, Cathers A. Initiation of inhaled nitric oxide by an air transport team in adult coronavirus disease 2019 respiratory failure. Air Medical Journal. 2022 Jul 1;41(4):406-10. https://doi.org/10.1016/j.amj.2022.03.001.
30. Alqahtani JS, Aldhahir AM, Al Ghamdi SS, AlBahrani S, AlDraiwiesh IA, Alqarni AA, Latief K, Raya RP, Oyelade T. Inhaled nitric oxide for clinical management of COVID-19: a systematic review and meta-analysis. International Journal of Environmental Research and Public Health. 2022 Oct 6;19(19):12803. https://doi.org/10.3390/ijerph191912803.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 P.R Arthi, Sushma Verma, Simranjeet Nanda, Jatin Khurana, Kasturi Pohini , Banani Jena (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
